Peregrine Capital Management LLC Glaukos Corp Transaction History

Peregrine Capital Management LLC

$3.18 Billion
Q3 2024

A detailed history of Peregrine Capital Management LLC transactions in Glaukos Corp stock. As of the latest transaction made, Peregrine Capital Management LLC holds 60,009 shares of GKOS stock, worth $9.05 Million. This represents 0.25% of its overall portfolio holdings.

Number of Shares

60,009

Previous 76,665 21.73%

Holding current value

$9.05 Million

Previous $9.07 Million 13.84%

% of portfolio

0.25%

Previous 0.27%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 24, 2024	SELL	$113.62 - $135.39 $1.89 Million - $2.26 Million	-16,656 Reduced 21.73%	60,009 $7.82 Million
Q2 2024 Jul 29, 2024	SELL	$89.48 - $118.35 $1.92 Million - $2.54 Million	-21,475 Reduced 21.88%	76,665 $9.07 Million
Q1 2024 Apr 26, 2024	SELL	$76.4 - $96.33 $72,656 - $91,609	-951 Reduced 0.96%	98,140 $9.25 Million
Q4 2023 Jan 26, 2024	SELL	$59.53 - $85.11 $1.05 Million - $1.51 Million	-17,690 Reduced 15.15%	99,091 $7.88 Million
Q3 2023 Oct 19, 2023	SELL	$69.23 - $79.09 $1.41 Million - $1.61 Million	-20,319 Reduced 14.82%	116,781 $8.79 Million
Q2 2023 Jul 26, 2023	SELL	$45.44 - $71.21 $1.36 Million - $2.13 Million	-29,872 Reduced 17.89%	137,100 $9.76 Million
Q1 2023 Apr 26, 2023	BUY	$43.88 - $52.48 $2.26 Million - $2.7 Million	51,520 Added 44.62%	166,972 $8.37 Million
Q4 2022 Jan 10, 2023	BUY	$40.82 - $57.75 $4.71 Million - $6.67 Million	115,452 New	115,452 $5.04 Million
Q2 2020 Jul 30, 2020	SELL	$28.78 - $46.83 $10.7 Million - $17.4 Million	-371,902 Closed	0 $0
Q1 2020 Apr 17, 2020	SELL	$25.53 - $70.14 $1.14 Million - $3.12 Million	-44,514 Reduced 10.69%	371,902 $11.5 Million
Q4 2019 Jan 16, 2020	BUY	$54.18 - $65.64 $3.73 Million - $4.51 Million	68,771 Added 19.78%	416,416 $22.7 Million
Q3 2019 Oct 16, 2019	BUY	$58.58 - $83.91 $5.98 Million - $8.57 Million	102,115 Added 41.59%	347,645 $21.7 Million
Q2 2019 Jul 18, 2019	BUY	$63.59 - $78.71 $1.33 Million - $1.64 Million	20,875 Added 9.29%	245,530 $0
Q1 2019 Apr 12, 2019	SELL	$50.75 - $80.54 $2.27 Million - $3.6 Million	-44,743 Reduced 16.61%	224,655 $0
Q4 2018 Jan 17, 2019	BUY	$52.18 - $67.93 $1.47 Million - $1.92 Million	28,256 Added 11.72%	269,398 $15.1 Million
Q3 2018 Oct 18, 2018	SELL	$38.13 - $68.37 $10.3 Million - $18.4 Million	-269,440 Reduced 52.77%	241,142 $0
Q2 2018 Jul 12, 2018	SELL	$27.62 - $44.51 $839,730 - $1.35 Million	-30,403 Reduced 5.62%	510,582 $0
Q1 2018 Apr 16, 2018	SELL	$26.05 - $34.5 $2.11 Million - $2.8 Million	-81,159 Reduced 13.05%	540,985 $0
Q4 2017 Jan 24, 2018	BUY	$24.5 - $36.01 $3.75 Million - $5.51 Million	152,990 Added 32.61%	622,144 $0
Q3 2017 Oct 25, 2017	BUY	$31.26 - $42.03 $14.7 Million - $19.7 Million	469,154	469,154 $0

Others Institutions Holding GKOS

# of Institutions

341

Shares Held

46.8M

Call Options Held

132K

Put Options Held

188K

View Full List

About GLAUKOS Corp

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $7.18B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

More about GKOS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.

Account

Peregrine Capital Management LLC Glaukos Corp Transaction History